Mission Bio, Inc. is innovating technologies to analyze single cells within complex biological systems, revealing critical information not observable from bulk sample analysis. With proprietary microfluidic droplet technology, Mission Bio is developing research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/06/17 | undisclosed | Seed |
Life Science Angels | undisclosed |
| 12/13/18 | $30,000,000 | Series B |
Agilent Technologies Cota Capital LAM Capital Mayfield Fund | undisclosed |
